Clinical Trial: A Study of LY2510924 in Patients With Extensive-Stage Small Cell Lung Carcinoma

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Randomized Phase 2 Study of LY2510924 and Carboplatin/Etoposide Versus Carboplatin/Etoposide in Extensive-Stage Small Cell Lung Carcinoma

Brief Summary: The purpose of this trial is to compare the progression free survival of LY2510924 + carboplatin + etoposide therapy versus carboplatin + etoposide therapy in patients with extensive-stage disease small cell lung cancer (SCLC)